Search

everythinglearnresearchcommunity

for

Search:↓

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Isotretinoin can cause serious birth defects and needs careful use, especially in pregnant women.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Thyroid receptor agonists may treat male pattern baldness without harmful side effects.

New genes linked to woolly hair have been found, which could help treat it and change hair texture.

Premature hair graying may be a sign of increased risk for heart disease, indicating biological age is more important than actual age.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Patients with oral lichen planus or oral lichenoid reactions had worse cholesterol levels and a higher risk of obesity compared to healthy individuals.

The document concludes that more research is needed to fully understand the causes of PCOS.

Metabolic syndrome is more common in people with early-onset androgenic alopecia.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Taiwanese women with PCOS experience different symptoms based on age, with younger women facing more hormone imbalances and older women dealing with more metabolic issues.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

Women with AGA have higher lipid levels, increasing heart disease risk.

A man developed heart problems after using a baldness treatment for 4 months, suggesting that people with heart issues should avoid this treatment.

Minoxidil may cause heart issues in guinea pigs, suggesting potential harm for users with heart conditions.

Young adults with hair loss face higher risk of stiff arteries.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Young women with PCOS without additional risk factors may have normal heart function.

Men with hair loss have higher BMI, waist size, blood pressure, and are linked to smoking and inactivity.

Oral minoxidil improves hair growth in men with hair loss, but caution needed for those with heart issues.